IDEXX Expands SediVue Dx® Analyzer Medical Utility and Imaging Capabilities with Latest Software Update

WESTBROOK, Maine, Jan. 21, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced an update to its SediVue Dx^® Urine Sediment Analyzer with its Neural Network 4.0 software release, expanding the analyzer's diagnostic capabilties. This update will be implemented across all SediVue Dx analyzer customers by the end of March, and reflects IDEXX's ongoing commitment to support the profession, advancing the standard of care with innovation. 

This update includes two new parameters that aid in assessing liver function and blood disorders in critical care situations. IDEXX's nearly 6,000 SediVue Dx analyzer customers worldwide will benefit from this release and the enhanced medical capabilities of the instrument when performing urine sediment analysis, a core component of a urinalysis.

"Urine sediment analysis is an important part of a patient's minimum diagnostic workup. With the SediVue Dx analyzer, I am more confident that I'm getting an accurate understanding of a patient's health status and the potential of underlying disease," said Dr. Roger Kendrick, Owner of Country Club Pet Hospital in Mansfield, TX. "The fact that my Sedivue Dx analyzer continues to get smarter over time and updates itself automatically is why I partner with IDEXX."

The two new crystals—ammonium biurate and bilirubin—form in the urine when certain liver dysfunction and blood disorders are present. These additional parameters help veterinarians understand when a patient might have a very serious liver or blood disease that requires immediate intervention.

An enhanced focus algorithm also provides even more detailed images in certain circumstances that enable more accurate identification of sediment in even the most complex samples.

This software update is powered by the world's largest veterinary database of 175 million veterinary patient-generated images from more than 2.5 million fresh patient urine samples.

"Revolutionary technology like the SediVue Dx analyzer and its Neural Network machine-learning capabilities are a product of IDEXX's relentless focus on innovation," said Jonathan Ayers, Chairman and Chief Executive Officer of IDEXX Laboratories. "With IDEXX SmartService Solutions, all SediVue Dx analyzers will immediately benefit from this software advancement."

IDEXX SmartService™ Solutions connects IDEXX devices globally, provides web-based customer service and support, and pushes regular updates to customers free of charge. For more information about IDEXX SmartService Solutions or the SediVue Dx Urine Sediment Analyzer, visit www.idexx.com.

About IDEXX Laboratories

IDEXX Laboratories, Inc. is a member of the S&P 500^® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency, and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 8,000 people and offers products to customers in over 175 countries. For more information about IDEXX, visit: www.idexx.com.

CONTACTS:
Media Relations
Robin Woodcock
1-207-632-8027
[email protected]

Investor Relations
Kerry Bennett
1-207-556-8155
[email protected]

SOURCE IDEXX Laboratories, Inc.

Related Links

http://www.idexx.com